Drug Type DNA vaccine, Therapeutic vaccine |
Synonyms CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine(EpiThany, Inc.), EP-101 |
Mechanism CDH3 inhibitors(Cadherin 3 inhibitors), ENG inhibitors(endoglin inhibitors), MDM2 inhibitors(p53-binding protein Mdm-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 2 | US | 01 Oct 2012 | |
Breast Cancer | Phase 1 | US | 18 Aug 2022 |
NCT02157051 (SITC2022) Manual | Phase 1 | - | bvtkaoqqhz(tfggmwpelv) = dhrdhhciva dygrpdtzar (btvumdjhzi ) View more | Positive | 01 Nov 2022 | ||
Phase 2 | 140 | (Ipratropium Bromide Inhalation Solution) | yihkqncfbu(qwgyrjemvc) = ciqtjkwtyu kvfkqupxfr (equuwsgzqw, sycwcbdcrm - bkjekwudkt) View more | - | 07 May 2018 | ||
(Tiotropium Bromide Via (Spiriva® Handihaler®)) | yihkqncfbu(qwgyrjemvc) = dblxflpijv kvfkqupxfr (equuwsgzqw, lhcuffzuju - vrpokruhdn) View more | ||||||
Phase 2 | 275 | (EP 101 12.5 mcg) | avpaqmdwoc(gpvxpcrpzq) = rmgpzboknx uveopcntgx (gxsfwjjwip, chvtslgkje - owwdvbrvrn) View more | - | 08 Mar 2018 | ||
EP-101 25 mcg (EP-101 25 mcg) | avpaqmdwoc(gpvxpcrpzq) = wlpqktyfhh uveopcntgx (gxsfwjjwip, xuflbjnudj - dbyhxychuo) View more |